Vancouver 2010 CNETS Canada Conference Program
Thursday May 13- Sunday May 16, 2010, at the Coast Plaza Hotel and Suites, in the heart of downtown Vancouver.
Welcome Reception, Thursday, 13 May 2010, 7.00 - 10:00 p.m.
Thursday, 13 May 2010
3:30 pm - Registration: Hotel Lobby.
3:00 - 5:00 pm - Learning how to Advocate (Barclay Room)
Presented by Ryan Clarke of Advocacy Solutions, attendees will learn about the basic concepts of advocacy, including what it is and why it’s important. We will also discuss how to advocate to government to bring about change, with an eye to some of the specific challenges facing neuroendocrine tumour patients and their caregivers.
The second part of the presentation will review the three core components of an effective advocacy strategy, providing the participants with a very practical, step-by-step process that will empower them to go away and immediately engage in advocacy.
And finally, attendees will be guided through all of the steps they need to advocate in person – how to get a meeting, how to prepare for a meeting, what to do at the meeting and how to follow up.
Please join us for this exciting session and learn how to become an advocate for change. Please RSVP to Maureen Coleman at maureenc@sympatico.ca.
7:00 - 10:00pm Casual Buffet: Lounge on the 35th floor of the Coast Plaza Hotel. Music Provided by Evelyn Loewen playing the Celtic Harp.
The Silent Auction opens 7:00 pm in the 35th floor lounge. The auction continues in the Denman Ballroom on Friday and Saturday, ending on the afternoon break on Saturday.
NeuroEndocrine Cancers: Networks of Expertise
Up to 20 Continuing Medical Education credits will be provided by the Canadian Association of Nuclear Medicine.
Learning Objectives: At the end of the symposium participants should be able to better:
- Recognize the signs of NeuroEndocrine tumour disease and the importance of early detection.
- Discuss current and emerging clinical practices in the diagnosis, treatment and follow up of NETs
- Discuss factors to evaluate in choosing among options for the management of advanced NET disease.
- Recognize the benefits of a multidisciplinary team approach to the comprehensive care of NET patients.
- Describe the collaborative interaction between health care professionals and patients in the management of NeuroEndocrine malignancies.
- Explore the relationship between NeuroEndocrine Research and Clinical Outcomes.
- Describe the NeuroEndocrine Model for the development and implementation of Personalized Medicine.
Friday, 14 May 2010 - (Denman Ballroom)
Breakfast Buffet begins at 7.00 AM in the Denman Ballroom.
Morning Sessions, 8:00 a.m. – 12:30 p.m. (with mid morning break)
8:00-8:05 - Welcome and Introduction - Maureen Coleman and Jim Kormos, President and Vice President CNETS Canada.
8:05-9:45 - Session 1- Chair: Dr. Ehud Ur.
An Overview of NETs: The Need for Networks of Expertise – Dr. Richard R.P. Warner
The Spectrum of Neuroendocrine Tumours - Dr. Simron Singh
Pathology of NETs - Dr. Sylvia Asa.
Chemotherapy and Biologic Therapy. What’s new in 2010 – Dr. Edward M Wolin
9:45.-10:35 - Session 2 - Chair: Dr. Edward M. Wolin
Multi Modality Patient Management Discussions
(Panel represents multidisciplinary specialties with access to full range of current multimodal resources)
Panel: Dr. Eric Krenning, Dr. Eugene Woltering, Dr. Aaron Vinik, Dr. Dermot O’Toole, .Dr. Bryan Dias, Dr. Sue O’Dorisio, Dr. Sylvia Asa, Dr. David Liu, Dr. Janice Pasieka.
Break 10:35-10:50
10:50-11:40-Session 3 - Surgery - Chair: Dr. Eric Liu
The Importance of Removing Primary and Secondary Tumors - Dr. Rodney Pommier
The Surgery of Lung NETs -Dr Christian Sirois
11:40-12:05 -Session 4 - Chair: Dr. Ehud Ur
Carcinoid Syndrome - What we have learned from the patients. Dr. Janice Pasieka
12.05-12.30 - Q and A
LUNCH 12:30 p.m. – 1:30 p.m.
1:00-1:15 - Former North Vancouver MP, Don Bell will speak about the 2008 Rare Disorders Private Member's Bill. (The Bill passed first and second reading in Ferderal Parliament in 2008 but died on the table following a Federal Election that year).
Afternoon Sessions 1:30 p.m. – 5:15 p.m. (with mid afternoon break)
1:30-1:55 - Session 5-Chair: Prof. Joy Ardill
Neuroendocrine Hormones: Why are they important? Dr Tony Heaney
1:55-3:15- Session 6 - NeuroEndocrine Research
Chair: Prof. Girish Shah – Research Session A
Circulating markers and prognostic indicators for NETs - Prof. Joy Ardill
In vitro receptor work in the MC Erasmus, Rotterdam lab - Dr. Wouter de Herder
Discovery of novel therapeutic approaches for CNETs using animal and cellular models - Prof. Girish Shah
Possible mechanism of NeuroEndocrine Tumor Chemo-Resistance - Dr. Tom O’Dorisio
Break: 3:15-3:30
3:30-4:10 - Session 7 – NeuroEndocrine Research Continued
Chair: Prof. Girish Shah – Research Session B
Sunitinib on Pancreatic endocrine tumours and MTOR in malignant insulinoma - Dr. Aaron Vinik
What's new in NETs research - are all of your tumors the same? - Dr. Eugene Woltering
4:10-5:10 - Session 8 - Chair: Dr. Ehud Ur – Clinical Trials
Clinical Trials: Their Importance and Relevance for GI Neuroendocrine Tumours - Dr. Daniel Rayson
Overview of Current and Planned Trials for Neuroendocrine Tumours - Dr. Hagen Kennecke
Ongoing Clinical Trials of Radioembolization in Neuroendocrine Tumours - Dr. Riad Salem
5:10-5:30 - Q and A
6:30-8:30 Dinner Buffet. Garden and Denman Ballroom. Cash Bar
8:00-8:30 Evening Dinner Lecture in Denman Ballroom - Dr. Jean Luc Urbain
Neuroendocrine Tumours and Personalized Medicine: The Barry Jackowich Memorial Lecture
8:.30-9:20 Inspirational and Healing songs performed by renowned singer composer Julie Blue. Introduction by Jennifer Weiss.
The Silent Auction continues throughout Friday till mid afternoon break on Saturday.
Saturday: 15 May 2010 (Denman Ballroom)
Morning Sessions: 8:00 a.m. – 12:30 p.m. (with mid morning break)
8:00-8:05 - Introductory Remarks - Representatives from the Board of CNETS Canada.
8:05-8:30 - Session 1- Chair: Dr Rodney Pommier
The Hard to Find Primary from the perspective of Surgery and Imaging - Dr Eric Liu
Mesenteric Resections - Dr Eric Liu
8:30-8:55 - Session 2- Chair: Dr Edward M Wolin
The Importance of Somatostatin Analogues - Dr Edward M Wolin
8:55-9:20 - Session 3- Chair: Dr Walter Kocha
Novel oral chemotherapy for metastatic pancreatic neuroendocrine cancers - Dr Larry Kvols
9:20-9:50 - Session 4- Keynote Speech - Chair: Dr Richard RP Warner
Expertise in NETWORLD: Illusion, Delusion or a Distant Reality? - Dr. Irvin Modlin
9:50-10:15 - Session 5 - Chair: Dr Aaron Vinik
Genetics of NETs - Dr. Sue O’Dorisio
10: 15-10:35 Break
10:35-11:25- Session 6 - Chair: Dr. Eugene Woltering
Multi Modality Patient Management Discussions
(Panel representing multidisciplinary specialties with access to full range of current multimodal resources)
Dr. John Buscombe, Dr. Richard R.P. Warner, Dr. Sharlene Gill, Dr Rodney Pommier, Prof Joy Ardill, Dr. Walter Kocha, Dr. Tom O’Dorisio, Dr. Wouter deHerder
11:25-11:50 - Session 7- Chair: Dr Wouter deHerder
Endoscopic ultrasound (EUS) and EUS-guided fine needle biopsy in the diagnosis and management of neuroendocrine tumours in 2010 - Dr. Dermot O’Toole
11:50-12:15-Session 8- Chair: Dr Christian Sirois
Diagnosis and Treatment of Lung Carcinoid Patients - Dr. Dan Granberg
12:15-12:45 - Q and A
LUNCH 12:45 p.m. – 1:45 p.m.
1:15-1:30 - Lunch time talk
NET Nurse Practitioner, Shirleen Chase.
Introduction to the role of the NET Nurse Practitioner
Shirleen will be available for informal concurrent sessions during the conference in conjunction with Clinical Nurse Specialist Riselda Granberg in an adjacent room.
Afternoon Sessions. 1:45 – 5:30 p.m. (with mid afternoon break)
1:45-2:10 - Session 9-Chair: Dr Ralph Wong
Cardiac Carcinoid Disease and Management -Dr. Bryan Dias
2:10-2:55 - Session 10 - Chair: Dr Tony Heaney
Interventional Radiology: Locoregional Therapies for NETs: Ablative Therapies - Dr David Liu
Chemo-embolizations & Y90 - Dr Riad Salem
2:55-3:20 Session 11 - Chair: Dr Larry Kvols
Guidelines in NETs. Their Rise and Limitations - Dr Walter Kocha
3:20-3:35 - Break
3:35-5:15 - Session 12 - Chair: Dr. Al Driedger - Nuclear Medicine Session
Is there a logical approach to imaging in NETs? - Dr John Buscombe
PRRT in the context of molecular and personalized medicine and future directions with regards to PRRT, based on animal research projects - Dr. Eric Krenning
Treatment with 177Lutetium-DOTA-Tyr3-octreotate in patients with neuroendocrine tumours - Dr. Dan Granberg
Treatment with Y-90 DOTATATE the UK experience - Dr John Buscombe
Isotope Treatment of bone metastases - Dr. Robert Reid
131I-mIBG in the treatment of patients with neuroendocrine tumours - Dr. Sandy McEwan
5:15-5:40- Q and A
Sunday: 16 May 2010 (Denman Ballroom)
Morning Session. 9:00 a.m. - 12:30 p.m. (with mid morning break)
Session 1- Chair: Dr Sandy McEwan
Guidelines for the Management of NeuroEndocrine Tumours: Presentations and Panel Discussions
Canadian Guidelines - Dr Ralph Wong, Dr Walter Kocha.
NANETS Guidelines - Dr Larry Kvols. Dr Sue Odorisio
ENETS Guidelines - Dr Wouter deHerder, Dr Dermot OToole
UKINETS Guidelines - Prof Joy Ardill, Dr John Buscombe
Session 2- Chair: Dr. Tom O’Dorisio
Where to from here: The Shape of 21st century Management and Care for all NeuroEndocrine Tumour and Cancer patients
Saturday 11.25 a.m. -12.10 a.m. - Special Music Therapy Session - Julie Blue
Friday and Saturday: The Patient work of the NET Nurse Practitioner and NET Clinical Nurse Specialist: - Shirleen Chase and Riselda Granberg. (Barclay Gilford room and Lobby). Please check for schedule.
CNETS Canada Organizing Task Force
Dr. Kathy Arbanasin, California, USA
Dr. Carol Bates, Director, CNETS Canada
Maureen Coleman, President, CNETS Canada
Dr. Al Driedger, Professor Emeritus, Canada
Jim Kormos, Vice President, CNETS Canada
Prof. Girish Shah, Director, CNETS Canada
Silvia Steinhilber, Treasurer, CNETS Canada
Dr. Jean Luc Urbain, Director, CNETS Canada